{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Little Ferry",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "87609",
      "recalling_firm": "Namoo Enterprise LLC",
      "address_1": "215 Gates Rd",
      "address_2": "Unit S",
      "postal_code": "07643-1930",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0351-2021",
      "product_description": "PremierZen Black 5000 capsules, 1 capsule per card/24 capsules per box, Distributed by New Premier Group Los Angeles CA 90006  UPC 7 2817542189 4",
      "product_quantity": "N/A",
      "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.",
      "recall_initiation_date": "20210325",
      "center_classification_date": "20210426",
      "termination_date": "20210716",
      "report_date": "20210505",
      "code_info": "All lots within expiry",
      "more_code_info": ""
    }
  ]
}